Answers are grounded in this paper and cite their sources.
Breast cancer continues to be a major global health concern with rising incidence worldwide. Although conventional treatments such as surgery, chemotherapy, radiotherapy, and targeted therapies have significantly improved clinical outcomes, they are often associated with treatment resistance, adverse effects, and disease recurrence. This has led to growing interest in integrative approaches that complement modern oncology with traditional medical systems such as Ayurveda. To explore an integrative treatment framework that combines contemporary breast cancer management with Ayurvedic principles and therapeutics, and to evaluate the scientific evidence supporting selected Ayurvedic medicinal plants in breast cancer care. This review examines breast cancer from both biomedical and Ayurvedic perspectives. It summarizes the molecular classification, risk factors, and diagnostic advancements in modern oncology, alongside Ayurvedic concepts such as Arbuda , Granthi , Tridosha imbalance, Kapha - Meda vitiation, Ama accumulation, and Dhatu Dushti . In addition, laboratory studies, animal experiments, clinical observations, and case reports were analyzed to assess the therapeutic potential of three Ayurvedic botanicals: Withania somnifera Dunal, Curcuma longa Linn., and Nelumbo nucifera Gaertn. Scientific evidence indicates that these botanicals exhibit anticancer and immunomodulatory activities, inhibit tumor growth pathways, and mitigate chemotherapy-related toxicity. Clinical reports suggest improvements in patient quality of life and survival when these therapies are integrated with standard treatments. Ayurvedic interventions such as Shodhana , Shamana , and Rasayana therapy and personalized diet based on Prakriti further support holistic patient care. Integrating Ayurveda with modern oncology shows promising potential for enhancing therapeutic efficacy and reducing treatment-related adverse effects in breast cancer care. However, rigorous large-scale clinical trials are essential to validate safety, establish standardized protocols, and ensure evidence-based integrative practice.
No takes yet. Share an insight, caveat, or question.
Garg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: